Modulation of cytotoxic effect of anticancer drugs by dipyridamole in HeLa cells in vitro. 1990

H Kusumoto, and Y Maehara, and Y Sakaguchi, and S Kohnoe, and R Kumashiro, and K Sugimachi
Cancer Center, Kyushu University Hospital, Faculty of Medicine, Kyushu University, Fukuoka, Japan.

Exponentially growing HeLa cells were treated with various antitumor drugs and dipyridamole (DP), and the cell growth inhibition ratio was determined. Enhanced growth inhibition was found in combined treatment with DP and 5-fluorouracil, 1-hexylcarbamoyl-5-fluorouracil, methotrexate, adriamycin, daunomycin, 4'-0-tetrahydropyranyl-adriamycin, actinomycin D and vincristine. In contrast, reduction of the cytotoxic effect of cytosine arabinoside and enocitabine was found when these were combined with DP.

UI MeSH Term Description Entries
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D004176 Dipyridamole A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752) Antistenocardin,Apo-Dipyridamole,Cerebrovase,Cléridium,Curantil,Curantyl,Dipyramidole,Kurantil,Miosen,Novo-Dipiradol,Persantin,Persantine,Apo Dipyridamole,Novo Dipiradol
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy

Related Publications

H Kusumoto, and Y Maehara, and Y Sakaguchi, and S Kohnoe, and R Kumashiro, and K Sugimachi
December 1990, Cancer treatment reviews,
H Kusumoto, and Y Maehara, and Y Sakaguchi, and S Kohnoe, and R Kumashiro, and K Sugimachi
May 1983, Gan to kagaku ryoho. Cancer & chemotherapy,
H Kusumoto, and Y Maehara, and Y Sakaguchi, and S Kohnoe, and R Kumashiro, and K Sugimachi
May 1986, Zhonghua zhong liu za zhi [Chinese journal of oncology],
H Kusumoto, and Y Maehara, and Y Sakaguchi, and S Kohnoe, and R Kumashiro, and K Sugimachi
September 1983, Cancer letters,
H Kusumoto, and Y Maehara, and Y Sakaguchi, and S Kohnoe, and R Kumashiro, and K Sugimachi
December 2023, Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS),
H Kusumoto, and Y Maehara, and Y Sakaguchi, and S Kohnoe, and R Kumashiro, and K Sugimachi
October 1992, International journal of cancer,
H Kusumoto, and Y Maehara, and Y Sakaguchi, and S Kohnoe, and R Kumashiro, and K Sugimachi
June 2002, Biological & pharmaceutical bulletin,
H Kusumoto, and Y Maehara, and Y Sakaguchi, and S Kohnoe, and R Kumashiro, and K Sugimachi
December 1990, Cancer research,
H Kusumoto, and Y Maehara, and Y Sakaguchi, and S Kohnoe, and R Kumashiro, and K Sugimachi
December 2009, Biochemical and biophysical research communications,
H Kusumoto, and Y Maehara, and Y Sakaguchi, and S Kohnoe, and R Kumashiro, and K Sugimachi
January 2021, Frontiers in molecular biosciences,
Copied contents to your clipboard!